Lusi Chen

机构：Jiangxi University of Traditional Chinese Medicine, Sun Yat-sen University, First People's Hospital of Foshan, Sun Yat-sen University Cancer Center

发表论文 62 篇 · 总被引 569 次 · h-index 14

代表论文

• Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma (2025 · JAMA · 被引 66)
• Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China (2025 · The Lancet · 被引 18)
• Syntheses, crystal structures, optical properties, antibacterial activity and DFT calculations of two substituted benzyl triphenylphosphinium picrates (2022 · Journal of Molecular Structure · 被引 14)
• Bioengineered composite hydrogel scaffold for accelerated skin regeneration and wound repair (2024 · Chemical Engineering Journal · 被引 13)
• Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngeal carcinoma (2023 · Frontiers in Immunology · 被引 13)
• Syntheses and biological activities of calix[4]resorcinarene derivatives modified by sulfonic acid and sulfonamides (2024 · RSC Advances · 被引 8)